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SUMMARY OF THESIS
CARVALHO, Enéas de - Análise das proteínas de Leptospira com possível papel hemolítico através de expressão recombinante: detecção de
expressão nativa, atividade biológica e potencial vacinal. São Paulo, 2008.   (Tese de doutoramento - Instituto de Biociências da Universidade
de São Paulo).
Leptospira HEMOLYTIC PROTEIN ANALYSIS BY THE RECOMBINANT EXPRESSION: DETECTION OF NATIVE
EXPRESSION, BIOLOGICAL ACTIVITY AND VACCINATION POTENTIAL
Leptospirosis is considered the most disseminated zoonosis of the
world, and also a reemerging disease. This disease, caused by
pathogenic bacteria of the genus Leptospira, has high rates of infection
in developing countries, leading to severe economic and medical costs.
There is not a licensed vaccine against leptospirosis for human use.
After the genome sequencing of three species of leptospires, several
genes were pointed to be promising vaccinal candidates. An important
category of these candidates are those with putative hemolytic activity.
In this work, we cloned and expressed some proteins with putative
hemolytic activity. The recombinant proteins obtained, however, did
not show hemolytic activity. One of these proteins, TlyC, was
investigated with regard to its possible ability to interact to extracellular
matrix (ECM) components. The results obtained indicate that TlyC
binds with high affinity to several ECM components and that this protein
can inhibit the leptospira bind to a biological material that resembles
the ECM. The transcription and expression of these proteins were
detected in leptospires cultures. Some of the recombinant proteins were
used in an animal challenge against leptospirosis, but none of them
were protective. We concluded that these proteins do not seem to be
good vaccine candidates and that TlyC is a protein that interacts with
the ECM and its components.
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